Non-invasive test for endometrial cancer screening
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests a simple, non-invasive method to detect endometrial cancer in women after menopause who have abnormal bleeding. It aims to find cancer early in those at higher risk, such as women with certain genetic conditions or risk factors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been through menopause for at least 1 year
- You have had abnormal uterine bleeding
- Your uterus lining is thicker than 3mm on an ultrasound, OR if it's 3mm or less, you have persistent bleeding, a mixed-texture lining, or risk factors like obesity, tamoxifen use, hormone therapy, Lynch syndrome, or BRCA gene change
- You are willing to give written consent
- You do not have an active pelvic infection or active hepatitis B, C, or HIV
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two less invasive methods—sampling cells from the lining of the uterus (endometrial cytology) and checking DNA changes in the cervix—to see if they can help detect endometrial cancer or atypical hyperplasia, and to monitor response in people who are preserving their fertility. It aims to find a gentler alternative to traditional biopsy.
This study uses a risk model to detect endometrial cancer in people with unexplained abnormal uterine bleeding. It aims to find better ways to identify cancer early without relying only on invasive biopsies.
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
This study looks at how well a surgical tool is used during standard surgery for early endometrial cancer, and whether it relates to test results from fluid taken in the abdomen. It may help surgeons improve how samples are collected and interpreted during routine care.
This trial tests a new way to take a small sample of the womb lining (biopsy) using a thin, flexible tube guided by ultrasound. The goal is to see if ultrasound guidance makes the biopsy more accurate and comfortable in people with post-menopausal bleeding.
This study looks at hormones in your urine to learn more about how uterine cancer develops in people with abnormal uterine bleeding. It may help find new ways to detect risk or catch problems earlier.
Hear when a new Endometrial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.